首页> 外文期刊>Quarterly Journal of Medicine >Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome
【24h】

Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome

机译:抗磷脂综合征中的抗磷脂,抗β2-糖蛋白-I和抗氧化的低密度脂蛋白抗体

获取原文
获取原文并翻译 | 示例
       

摘要

Antiphospholipid antibodies (aPL), anti-β2-glyco- protein I (anti-β2-GPI) and anti-oxidized-low- density lipoprotein (LDL) antibodies are all implic- ated in the pathogensis of antiphisholipid syndrome. To investigate whether different autoanti- bodies or combinations thereof produced distinct effects related to their antigenic specificities, we examined the frequencies of antiphospholipid syn- drome (APS)-related features in the presence of dif- ferent antibodies [aPL, β2-GPI, anti-oxidized low density lipoprotein (LDL)] in 125 patients with APS.
机译:抗磷脂抗体(aPL),抗β2-糖蛋白I(抗β2-GPI)和抗氧化低密度脂蛋白(LDL)抗体均与抗磷脂综合征相关。为了研究不同的自身抗体或其组合是否产生与其抗原特异性相关的不同作用,我们检查了在存在不同抗体[aPL,β2-GPI,抗氧化型低密度脂蛋白(LDL)]在125例APS患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号